In this issue:
Ciclosporin vs prednisolone in pyoderma gangrenosum
Systemic psoriasis therapies and the risk of herpes zoster
Risk of next melanoma
Preferences for biopsy result notification
No association between malignancy and topical pimecrolimus
Drug survival for ciclosporin in atopic dermatitis
Topical ivermectin vs metronidazole in rosacea
Secukinumab for moderate to severe psoriasis
Tavaborole solution for toenail onychomycosis
Apremilast for moderate to severe psoriasis
Contact sensitisation due to cosmetics
Please login below to download this issue (PDF)